Walker Janice L, Wolff Iris M, Zhang Liping, Menko A Sue
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Invest Ophthalmol Vis Sci. 2007 May;48(5):2214-23. doi: 10.1167/iovs.06-1059.
Posterior capsule opacification (PCO) is a complication of cataract surgery resulting from the proliferation, migration, and epithelial-to-mesenchymal transition (EMT) of lens epithelial cells that remain associated with the lens capsule. These changes cause a loss of vision. The authors developed a chick embryo lens capsular bag model to study mechanisms involved in the onset of PCO. Because Src family kinases (SFKs) signal cell proliferation, migration, and EMT, the authors examined whether the inhibition of SFKs can prevent PCO.
After mock cataract surgery, chick lens capsular bags were pinned to a culture dish and grown in the presence or absence of the SFK inhibitor PP1. Cell movement was followed by photomicroscopy. Progression of proliferation and EMT in the PCO cultures was determined by Western blot analysis and immunofluorescence staining.
As occurs in PCO, lens cells in this model proliferated, migrated across the posterior capsule, and expressed EMT markers, alpha-smooth muscle actin (alpha-SMA), and fibronectin (FN). Lens cells treated with PP1 maintained an epithelial phenotype, accumulated cadherin junctions, and did not migrate to the posterior capsule, increase proliferation, or express EMT markers. Therefore, exposure to PP1 prevented PCO. Short-term inhibition of SFKs was sufficient to prevent EMT, but longer inhibition was necessary to prevent lens cell migration.
Progression of PCO involved early activation of SFKs. Lens cell migration preceded EMT, and each of these two events required activation of an SFK signaling pathway. Suppression of SFK activation blocked PCO, suggesting SFKs as a therapeutic target for the prevention of PCO.
后囊膜混浊(PCO)是白内障手术的一种并发症,由与晶状体囊膜相连的晶状体上皮细胞增殖、迁移以及上皮-间充质转化(EMT)引起。这些变化会导致视力丧失。作者建立了鸡胚晶状体囊袋模型来研究PCO发病机制。由于Src家族激酶(SFKs)参与细胞增殖、迁移及EMT信号传导,作者研究了抑制SFKs是否能预防PCO。
模拟白内障手术后,将鸡晶状体囊袋固定于培养皿,在有或无SFK抑制剂PP1的情况下培养。通过显微镜观察细胞运动。采用蛋白质印迹分析和免疫荧光染色法测定PCO培养物中增殖和EMT的进展情况。
在此模型中,晶状体细胞如在PCO中一样发生增殖,穿过后囊膜迁移,并表达EMT标志物α-平滑肌肌动蛋白(α-SMA)和纤连蛋白(FN)。用PP1处理的晶状体细胞维持上皮表型,积累钙黏蛋白连接,未迁移至后囊膜,未增加增殖,也未表达EMT标志物。因此,暴露于PP1可预防PCO。短期抑制SFKs足以预防EMT,但需要更长时间的抑制才能阻止晶状体细胞迁移。
PCO的进展涉及SFKs的早期激活。晶状体细胞迁移先于EMT,这两个事件均需激活SFK信号通路。抑制SFK激活可阻断PCO,提示SFKs可作为预防PCO的治疗靶点。